Hypertension Management Devices Market size is expected to grow at 17.24% throughout the forecast period, reaching nearly US$ 11.28 Bn. by 2029. Hypertension was considered a burden from mainly of industrialized nations, largely due to complex genetic–environmental and social interactions. This may adversely affect both future cardiovascular events and mortality. While the disease burden continues to rise among industrialized nations, current trends also show a rapidly rising prevalence in developing nations.To know about the Research Methodology :- Request Free Sample Report Hypertension management device is the more effective and efficient way to manage the patients suffering from hypertension and other chronic disorders. Hypertension management devices is the great evolvement in healthcare compared to other conventional medicines and therapeutics available. The report on the Global Hypertension Management Devices Market gives an estimation of the development of the market based on historical studies and also provides forecasts based on a comprehensive research. The report gives a complete market analysis for the forecast period from 2023 to 2029. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. Some of the major key players in the global market includes Medtronic Inc., Boston Scientific, Cordis, St. Jude Medical, Recor Medical. The market size in terms of revenue and volume is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Hypertension Management Devices Market Dynamics
Currently, available hypertension management devices, with recent novel structures targeting the renal sympathetic nervous system offer the potential for a previously undertreated group of patients with resistant hypertension. Hypertension Management devices are used for many reasons like to cure illnesses and health conditions, to prevent or delay future health care problems, to reduce pain and increase quality of life, and sometimes merely to obtain information about their health status and prognosis. Many of people with hypertension are undiagnosed, and of those diagnosed, around half are not taking antihypertensive medications, for this situation the hypertension management devices work better in treatment and cure. Hypertension management devices with emerging technologies might support improved detection and management of hypertension not only in the wider population but also within special population groups such as the elderly, pregnant women, and those with atrial fibrillation. Global Hypertension Management Devices Market is segmented by device type, technology, End User and region. The Renal Denervation Devices segment commands the hypertension management devices market & share the xx% of revenue in total market. Renal denervation device is a promising contemporary evolution of a historical treatment for hypertension and aims to achieve a reduction in renal sympathetic activation. These devices have been shown to be important in both resistant hypertension and in other disease states including heart failure. Renal denervation device using catheter-based technology showed promise effects for treatment of resistant hypertension, with few undesirable side effects. Clinical research studies proved that RDD can prevent, reverse, or reduce the severity of hypertension, paving the way for human trials. Currently, RDD that only commercially available device with randomized controlled trial evidence to support its clinical use in hypertension and cardiovascular disorders. The key players those are successful in launching the renal denervation devices are St Jude Medical, Boston Scientific, Covidien, ReCor Medical. The good safety profile given by the RDD is the major factor driving the global market during forecast period. Features like cost-effective analysis and the limited duration of patient follow-up is the key factors for the renal denervation devices segment to command the largest market share of xx% by 2029. Despite the initial capital cost of the generator and the associated device and procedure costs, on a per-patient basis, RDN appears to be a highly cost-effective procedure. Numerous novel device technologies are under development, and existing catheter systems in hypertension management devices continue to be improved, which help to grow the global market during forecast period. Radiofrequency ablation (RFA) is thought to decrease both the afferent sympathetic signals from the kidney to the brain and the efferent signals from the brain to the kidney. The procedure decreases sympathetic activation, decreases vasoconstriction, and decreases activation of the renin-angiotensin system, which helps to release the stress of patients suffering from hypertension. Radiofrequency ablation (RFA) is a new buzz in the treatment of hypertension and interventional cardiology. Recent advances in RFA have allowed transvascular techniques that are minimally invasive and can be delivered expeditiously and safely. Radio frequency ablation technology shows time-dependent interventions during treatment procedure and examine approaches used in humans and in the many experimental models that offer a better understanding of the role of sympathetic activity in cardiovascular disease. Radiofrequency ablation energy sources are currently the preferred modalities and hence this technique under intense investigation. The results by RFA have been encouraging and offer promise for the future growth of the global market. This technology focus on methods and techniques addressing sympathetic renal denervation in patients with drug-resistant hypertension, which in turn drive the global market during forecast period by 2029. Physicians treat chronic diseases and hypertension almost exclusively in ambulatory care settings. From the analysis of national data of hospitalizations, it seems that hypertension is listed as a primary diagnosis for 301 000 admissions and secondary diagnosis for 9 003 000 hospitalized patients, this created the need for hypertension management devices in hospitals and in ambulatory care centers. The use of hypertension management devices in long-term control and treatment, shows results in prevention of cardiovascular complications; controlling BP in patients hospitalized for reasons other than hypertension. Improved detection and treatment of hypertension in ambulatory care settings would reduce a preventable burden of cardiac, cerebrovascular (ischemic and haemorrhagic stroke) and renal disease related to hypertension. The use of hypertension management devices as a primary care in hospitals creates the scope for growth of the global market during forecast period. The standard guidelines for prevention, screening, diagnosis and management & monitoring in cardiovascular and central nervous system related disorders from the healthcare sector, is expected to grow the ambulatory care settings segment globally.Hypertension is a widely prevalent condition, which is estimated to affect approximately 30% of the population in the United States. Hence, North America is expected to command largest market share of xx% by 29. Comparative examination of hypertension management devices and analysis of their working structure by health care professionals from North America drive the global market during forecast period. Appropriate health care facility utilization by patients and high quality, inexpensive services given by doctors and physicians are helping to drive the global hypertension management devices market from this region substancially. Focus on future health care needs, health care expenditure, and increased personnel training for handling hypertension management devices, helps to increase the level of treatment standardization in this region. New and emerging technologies in hypertension management devices have changed patterns of care and moving towards user-friendly devices, as a result, the region is dominant in the global market growth. Public and Private organizations have made great strides in identifying causes of disease and disability, discovering treatments and cures, and working with practitioners to educate the public about how to reduce the incidence of hypertension and prevalence of major diseases and the functional limitations and discomfort they may cause. As a result hypertension management devices have major contribution in hospitalization from developed, developing and underdeveloped countries.
Scope of the Hypertension Management Devices Market: Inquire Before Buying
Global Hypertension Management Devices Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 17.24% US$ 3.70 Bn US$ 11.28 Bn Segments Covered by Device Type Renal Denervation Devices Carotid Sinus Stimulation Devices Others by Technology Radiofrequency Ablation Ultrasound Micro-infusion Others by Application Hospitals Ambulatory care Settings Clinics Home Care Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Key Players are:
1. Medtronic Inc. 2. Boston Scientific 3. Cordis 4. St. Jude Medical 5. Recor Medical 6. Intercure 7. CVRX 8. Mercator Medsystems 9. Kona Medical 10.Abbott 11.Ablative Solutions Inc. 12.PhysioCue Frequently Asked questions 1. What is the market size of the Global Hypertension Management Devices Market in 2022? Ans. The market size Global Hypertension Management Devices Market in 2022 was US$ 3.70 Billion. 2. What are the different segments of the Global Hypertension Management Devices Market ? Ans. The Global Hypertension Management Devices Market is divided into Device Type, Application and Technology. 3. What is the study period of this market? Ans. The Global Hypertension Management Devices Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Hypertension Management Devices Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Hypertension Management Devices Market ? Ans. The Forecast Period of the market is 2023-2029 in the market.
Global Hypertension Management Devices Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Hypertension Management Devices Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Hypertension Management Devices Market Analysis and Forecast 6.1. Hypertension Management Devices Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Hypertension Management Devices Market Analysis and Forecast, by Device Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Hypertension Management Devices Market Value Share Analysis, by Device Type 7.4. Hypertension Management Devices Market Size (US$ Mn) Forecast, by Device Type 7.5. Hypertension Management Devices Market Analysis, by Device Type 7.6. Hypertension Management Devices Market Attractiveness Analysis, by Device Type 8. Global Hypertension Management Devices Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Hypertension Management Devices Market Value Share Analysis, by Technology 8.4. Hypertension Management Devices Market Size (US$ Mn) Forecast, by Technology 8.5. Hypertension Management Devices Market Analysis, by Technology 8.6. Hypertension Management Devices Market Attractiveness Analysis, by Technology 9. Global Hypertension Management Devices Market Analysis and Forecast by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Hypertension Management Devices Market Value Share Analysis, by End User 9.4. Hypertension Management Devices Market Size (US$ Mn) Forecast, by End User 9.5. Hypertension Management Devices Market Analysis, by End User 9.6. Hypertension Management Devices Market Attractiveness Analysis, by End User 10. Global Hypertension Management Devices Market Analysis, by Region 10.1. Hypertension Management Devices Market Value Share Analysis, by Region 10.2. Hypertension Management Devices Market Size (US$ Mn) Forecast, by Region 10.3. Hypertension Management Devices Market Attractiveness Analysis, by Region 11. North America Hypertension Management Devices Market Analysis 11.1. Key Findings 11.2. North America Hypertension Management Devices Market Overview 11.3. North America Hypertension Management Devices Market Value Share Analysis, by Device Type 11.4. North America Hypertension Management Devices Market Forecast, by Device Type 11.4.1. Renal Denervation Devices 11.4.2. Carotid Sinus Stimulation Devices 11.4.3. Others 11.5. North America Hypertension Management Devices Market Value Share Analysis, by Technology 11.6. North America Hypertension Management Devices Market Forecast, by Technology 11.6.1. Radiofrequency Ablation 11.6.2. Ultrasound 11.6.3. Micro-infusion 11.6.4. Others 11.7. North America Hypertension Management Devices Market Value Share Analysis, by End User 11.8. North America Hypertension Management Devices Market Forecast, by End User 11.8.1. Hospitals 11.8.2. Ambulatory care Settings 11.8.3. Clinics 11.8.4. Home Care 11.9. North America Hypertension Management Devices Market Value Share Analysis, by Country 11.10. North America Hypertension Management Devices Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America Hypertension Management Devices Market Analysis, by Country 11.12. U.S. Hypertension Management Devices Market Forecast, by Device Type 11.12.1. Renal Denervation Devices 11.12.2. Carotid Sinus Stimulation Devices 11.12.3. Others 11.13. U.S. Hypertension Management Devices Market Forecast, by Technology 11.13.1. Radiofrequency Ablation 11.13.2. Ultrasound 11.13.3. Micro-infusion 11.13.4. Others 11.14. U.S. Hypertension Management Devices Market Forecast, by End User 11.14.1. Hospitals 11.14.2. Ambulatory care Settings 11.14.3. Clinics 11.14.4. Home Care 11.15. Canada Hypertension Management Devices Market Forecast, by Device Type 11.15.1. Renal Denervation Devices 11.15.2. Carotid Sinus Stimulation Devices 11.15.3. Others 11.16. Canada Hypertension Management Devices Market Forecast, by Technology 11.16.1. Radiofrequency Ablation 11.16.2. Ultrasound 11.16.3. Micro-infusion 11.16.4. Others 11.17. Canada Hypertension Management Devices Market Forecast, by End User 11.17.1. Hospitals 11.17.2. Ambulatory care Settings 11.17.3. Clinics 11.17.4. Home Care 11.18. Mexico Hypertension Management Devices Market Forecast, by Device Type 11.18.1. Renal Denervation Devices 11.18.2. Carotid Sinus Stimulation Devices 11.18.3. Others 11.19. Mexico Hypertension Management Devices Market Forecast, by Technology 11.19.1. Radiofrequency Ablation 11.19.2. Ultrasound 11.19.3. Micro-infusion 11.19.4. Others 11.20. Mexico Hypertension Management Devices Market Forecast, by End User 11.20.1. Hospitals 11.20.2. Ambulatory care Settings 11.20.3. Clinics 11.20.4. Home Care 11.21. North America Hypertension Management Devices Market Attractiveness Analysis 11.21.1. by Device Type 11.21.2. by Technology 11.21.3. by End User 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe Hypertension Management Devices Market Analysis 12.1. Key Findings 12.2. Europe Hypertension Management Devices Market Overview 12.3. Europe Hypertension Management Devices Market Value Share Analysis, by Device Type 12.4. Europe Hypertension Management Devices Market Forecast, by Device Type 12.4.1. Renal Denervation Devices 12.4.2. Carotid Sinus Stimulation Devices 12.4.3. Others 12.5. Europe Hypertension Management Devices Market Value Share Analysis, by Technology 12.6. Europe Hypertension Management Devices Market Forecast, by Technology 12.6.1. Radiofrequency Ablation 12.6.2. Ultrasound 12.6.3. Micro-infusion 12.6.4. Others 12.7. Europe Hypertension Management Devices Market Value Share Analysis, by End User 12.8. Europe Hypertension Management Devices Market Forecast, by End User 12.8.1. Hospitals 12.8.2. Ambulatory care Settings 12.8.3. Clinics 12.8.4. Home Care 12.9. Europe Hypertension Management Devices Market Value Share Analysis, by Country 12.10. Europe Hypertension Management Devices Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany Hypertension Management Devices Market Forecast, by Device Type 12.11.1. Renal Denervation Devices 12.11.2. Carotid Sinus Stimulation Devices 12.11.3. Others 12.12. Germany Hypertension Management Devices Market Forecast, by Technology 12.12.1. Radiofrequency Ablation 12.12.2. Ultrasound 12.12.3. Micro-infusion 12.12.4. Others 12.13. Germany Hypertension Management Devices Market Forecast, by End User 12.13.1. Hospitals 12.13.2. Ambulatory care Settings 12.13.3. Clinics 12.13.4. Home Care 12.14. U.K. Hypertension Management Devices Market Forecast, by Device Type 12.14.1. Renal Denervation Devices 12.14.2. Carotid Sinus Stimulation Devices 12.14.3. Others 12.15. U.K. Hypertension Management Devices Market Forecast, by Technology 12.15.1. Radiofrequency Ablation 12.15.2. Ultrasound 12.15.3. Micro-infusion 12.15.4. Others 12.16. U.K. Hypertension Management Devices Market Forecast, by End User 12.16.1. Hospitals 12.16.2. Ambulatory care Settings 12.16.3. Clinics 12.16.4. Home Care 12.17. France Hypertension Management Devices Market Forecast, by Device Type 12.17.1. Renal Denervation Devices 12.17.2. Carotid Sinus Stimulation Devices 12.17.3. Others 12.18. France Hypertension Management Devices Market Forecast, by Technology 12.18.1. Radiofrequency Ablation 12.18.2. Ultrasound 12.18.3. Micro-infusion 12.18.4. Others 12.19. France Hypertension Management Devices Market Forecast, by End User 12.19.1. Hospitals 12.19.2. Ambulatory care Settings 12.19.3. Clinics 12.19.4. Home Care 12.20. Italy Hypertension Management Devices Market Forecast, by Device Type 12.20.1. Renal Denervation Devices 12.20.2. Carotid Sinus Stimulation Devices 12.20.3. Others 12.21. Italy Hypertension Management Devices Market Forecast, by Technology 12.21.1. Radiofrequency Ablation 12.21.2. Ultrasound 12.21.3. Micro-infusion 12.21.4. Others 12.22. Italy Hypertension Management Devices Market Forecast, by End User 12.22.1. Hospitals 12.22.2. Ambulatory care Settings 12.22.3. Clinics 12.22.4. Home Care 12.23. Spain Hypertension Management Devices Market Forecast, by Device Type 12.23.1. Renal Denervation Devices 12.23.2. Carotid Sinus Stimulation Devices 12.23.3. Others 12.24. Spain Hypertension Management Devices Market Forecast, by Technology 12.24.1. Radiofrequency Ablation 12.24.2. Ultrasound 12.24.3. Micro-infusion 12.24.4. Others 12.25. Spain Hypertension Management Devices Market Forecast, by End User 12.25.1. Hospitals 12.25.2. Ambulatory care Settings 12.25.3. Clinics 12.25.4. Home Care 12.26. Sweden Hypertension Management Devices Market Forecast, by Device Type 12.26.1. Renal Denervation Devices 12.26.2. Carotid Sinus Stimulation Devices 12.26.3. Others 12.27. Sweden Hypertension Management Devices Market Forecast, by Technology 12.27.1. Radiofrequency Ablation 12.27.2. Ultrasound 12.27.3. Micro-infusion 12.27.4. Others 12.28. Sweden Hypertension Management Devices Market Forecast, by End User 12.28.1. Hospitals 12.28.2. Ambulatory care Settings 12.28.3. Clinics 12.28.4. Home Care 12.29. CIS countries Hypertension Management Devices Market Forecast, by Device Type 12.29.1. Renal Denervation Devices 12.29.2. Carotid Sinus Stimulation Devices 12.29.3. Others 12.30. CIS countries Hypertension Management Devices Market Forecast, by Technology 12.30.1. Radiofrequency Ablation 12.30.2. Ultrasound 12.30.3. Micro-infusion 12.30.4. Others 12.31. CIS countries Hypertension Management Devices Market Forecast, by End User 12.31.1. Hospitals 12.31.2. Ambulatory care Settings 12.31.3. Clinics 12.31.4. Home Care 12.32. Rest of Europe Hypertension Management Devices Market Forecast, by Device Type 12.32.1. Renal Denervation Devices 12.32.2. Carotid Sinus Stimulation Devices 12.32.3. Others 12.33. Rest of Europe Hypertension Management Devices Market Forecast, by Technology 12.33.1. Radiofrequency Ablation 12.33.2. Ultrasound 12.33.3. Micro-infusion 12.33.4. Others 12.34. Rest of Europe Hypertension Management Devices Market Forecast, by End User 12.34.1. Hospitals 12.34.2. Ambulatory care Settings 12.34.3. Clinics 12.34.4. Home Care 12.35. Europe Hypertension Management Devices Market Attractiveness Analysis 12.35.1. by Technology 12.35.2. by Device Type 12.35.3. by End User 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific Hypertension Management Devices Market Analysis 13.1. Key Findings 13.2. Asia Pacific Hypertension Management Devices Market Overview 13.3. Asia Pacific Hypertension Management Devices Market Value Share Analysis, by Device Type 13.4. Asia Pacific Hypertension Management Devices Market Forecast, by Device Type 13.4.1. Renal Denervation Devices 13.4.2. Carotid Sinus Stimulation Devices 13.4.3. Others 13.5. Asia Pacific Hypertension Management Devices Market Value Share Analysis, by Technology 13.6. Asia Pacific Hypertension Management Devices Market Forecast, by Technology 13.6.1. Radiofrequency Ablation 13.6.2. Ultrasound 13.6.3. Micro-infusion 13.6.4. Others 13.7. Asia Pacific Hypertension Management Devices Market Value Share Analysis, by End User 13.8. Asia Pacific Hypertension Management Devices Market Forecast, by End User 13.8.1. Hospitals 13.8.2. Ambulatory care Settings 13.8.3. Clinics 13.8.4. Home Care 13.9. Asia Pacific Hypertension Management Devices Market Value Share Analysis, by Country 13.10. Asia Pacific Hypertension Management Devices Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific Hypertension Management Devices Market Analysis, by Country 13.12. China Hypertension Management Devices Market Forecast, by Device Type 13.12.1. Renal Denervation Devices 13.12.2. Carotid Sinus Stimulation Devices 13.12.3. Others 13.13. China Hypertension Management Devices Market Forecast, by Technology 13.13.1. Radiofrequency Ablation 13.13.2. Ultrasound 13.13.3. Micro-infusion 13.13.4. Others 13.14. China Hypertension Management Devices Market Forecast, by End User 13.14.1. Hospitals 13.14.2. Ambulatory care Settings 13.14.3. Clinics 13.14.4. Home Care 13.15. India Hypertension Management Devices Market Forecast, by Device Type 13.15.1. Renal Denervation Devices 13.15.2. Carotid Sinus Stimulation Devices 13.15.3. Others 13.16. India Hypertension Management Devices Market Forecast, by Technology 13.16.1. Radiofrequency Ablation 13.16.2. Ultrasound 13.16.3. Micro-infusion 13.16.4. Others 13.17. India Hypertension Management Devices Market Forecast, by End User 13.17.1. Hospitals 13.17.2. Ambulatory care Settings 13.17.3. Clinics 13.17.4. Home Care 13.18. Japan Hypertension Management Devices Market Forecast, by Device Type 13.18.1. Renal Denervation Devices 13.18.2. Carotid Sinus Stimulation Devices 13.18.3. Others 13.19. Japan Hypertension Management Devices Market Forecast, by Technology 13.19.1. Radiofrequency Ablation 13.19.2. Ultrasound 13.19.3. Micro-infusion 13.19.4. Others 13.20. Japan Hypertension Management Devices Market Forecast, by End User 13.20.1. Hospitals 13.20.2. Ambulatory care Settings 13.20.3. Clinics 13.20.4. Home Care 13.21. South Korea Hypertension Management Devices Market Forecast, by Device Type 13.21.1. Renal Denervation Devices 13.21.2. Carotid Sinus Stimulation Devices 13.21.3. Others 13.22. South Korea Hypertension Management Devices Market Forecast, by Technology 13.22.1. Radiofrequency Ablation 13.22.2. Ultrasound 13.22.3. Micro-infusion 13.22.4. Others 13.23. South Korea Hypertension Management Devices Market Forecast, by End User 13.23.1. Hospitals 13.23.2. Ambulatory care Settings 13.23.3. Clinics 13.23.4. Home Care 13.24. Australia Hypertension Management Devices Market Forecast, by Device Type 13.24.1. Renal Denervation Devices 13.24.2. Carotid Sinus Stimulation Devices 13.24.3. Others 13.25. Australia Hypertension Management Devices Market Forecast, by Technology 13.25.1. Radiofrequency Ablation 13.25.2. Ultrasound 13.25.3. Micro-infusion 13.25.4. Others 13.26. Australia Hypertension Management Devices Market Forecast, by End User 13.26.1. Hospitals 13.26.2. Ambulatory care Settings 13.26.3. Clinics 13.26.4. Home Care 13.27. ASEAN Hypertension Management Devices Market Forecast, by Device Type 13.27.1. Renal Denervation Devices 13.27.2. Carotid Sinus Stimulation Devices 13.27.3. Others 13.28. ASEAN Hypertension Management Devices Market Forecast, by Technology 13.28.1. Radiofrequency Ablation 13.28.2. Ultrasound 13.28.3. Micro-infusion 13.28.4. Others 13.29. ASEAN Hypertension Management Devices Market Forecast, by End User 13.29.1. Hospitals 13.29.2. Ambulatory care Settings 13.29.3. Clinics 13.29.4. Home Care 13.30. Rest of Asia Pacific Hypertension Management Devices Market Forecast, by Device Type 13.30.1. Renal Denervation Devices 13.30.2. Carotid Sinus Stimulation Devices 13.30.3. Others 13.31. Rest of Asia Pacific Hypertension Management Devices Market Forecast, by Technology 13.31.1. Radiofrequency Ablation 13.31.2. Ultrasound 13.31.3. Micro-infusion 13.31.4. Others 13.32. Rest of Asia Pacific Hypertension Management Devices Market Forecast, by End User 13.32.1. Hospitals 13.32.2. Ambulatory care Settings 13.32.3. Clinics 13.32.4. Home Care 13.33. Asia Pacific Hypertension Management Devices Market Attractiveness Analysis 13.33.1. by Device Type 13.33.2. by Technology 13.33.3. by End User 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa Hypertension Management Devices Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Hypertension Management Devices Market Overview 14.3. Middle East & Africa Hypertension Management Devices Market Value Share Analysis, by Device Type 14.4. Middle East & Africa Hypertension Management Devices Market Forecast, by Device Type 14.4.1. Renal Denervation Devices 14.4.2. Carotid Sinus Stimulation Devices 14.4.3. Others 14.5. Middle East & Africa Hypertension Management Devices Market Value Share Analysis, by Technology 14.6. Middle East & Africa Hypertension Management Devices Market Forecast, by Technology 14.6.1. Radiofrequency Ablation 14.6.2. Ultrasound 14.6.3. Micro-infusion 14.6.4. Others 14.7. Middle East & Africa Hypertension Management Devices Market Value Share Analysis, by End User 14.8. Middle East & Africa Hypertension Management Devices Market Forecast, by End User 14.8.1. Hospitals 14.8.2. Ambulatory care Settings 14.8.3. Clinics 14.8.4. Home Care 14.9. Middle East & Africa Hypertension Management Devices Market Value Share Analysis, by Country 14.10. Middle East & Africa Hypertension Management Devices Market Forecast, by Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa Hypertension Management Devices Market Analysis, by Country 14.12. GCC Countries Hypertension Management Devices Market Forecast, by Device Type 14.12.1. Renal Denervation Devices 14.12.2. Carotid Sinus Stimulation Devices 14.12.3. Others 14.13. GCC Countries Hypertension Management Devices Market Forecast, by Technology 14.13.1. Radiofrequency Ablation 14.13.2. Ultrasound 14.13.3. Micro-infusion 14.13.4. Others 14.14. GCC Countries Hypertension Management Devices Market Forecast, by End User 14.14.1. Hospitals 14.14.2. Ambulatory care Settings 14.14.3. Clinics 14.14.4. Home Care 14.15. South Africa Hypertension Management Devices Market Forecast, by Device Type 14.15.1. ACC 14.15.2. Renal Denervation Devices 14.15.3. Carotid Sinus Stimulation Devices 14.15.4. Others 14.16. South Africa Hypertension Management Devices Market Forecast, by Technology 14.16.1. Radiofrequency Ablation 14.16.2. Ultrasound 14.16.3. Micro-infusion 14.16.4. Others 14.17. South Africa Hypertension Management Devices Market Forecast, by End User 14.17.1. Hospitals 14.17.2. Ambulatory care Settings 14.17.3. Clinics 14.17.4. Home Care 14.18. Nigeria Hypertension Management Devices Market Forecast, by Device Type 14.18.1. Renal Denervation Devices 14.18.2. Carotid Sinus Stimulation Devices 14.18.3. Others 14.19. Nigeria Hypertension Management Devices Market Forecast, by Technology 14.19.1. Radiofrequency Ablation 14.19.2. Ultrasound 14.19.3. Micro-infusion 14.19.4. Others 14.20. Nigeria Hypertension Management Devices Market Forecast, by End User 14.20.1. Hospitals 14.20.2. Ambulatory care Settings 14.20.3. Clinics 14.20.4. Home Care 14.21. Egypt Hypertension Management Devices Market Forecast, by Device Type 14.21.1. Renal Denervation Devices 14.21.2. Carotid Sinus Stimulation Devices 14.21.3. Others 14.22. Egypt Hypertension Management Devices Market Forecast, by Technology 14.22.1. Radiofrequency Ablation 14.22.2. Ultrasound 14.22.3. Micro-infusion 14.22.4. Others it 14.23. Egypt Hypertension Management Devices Market Forecast, by End User 14.23.1. Hospitals 14.23.2. Ambulatory care Settings 14.23.3. Clinics 14.23.4. Home Care 14.24. Rest of Middle East & Africa Hypertension Management Devices Market Forecast, by Device Type 14.24.1. Renal Denervation Devices 14.24.2. Carotid Sinus Stimulation Devices 14.24.3. Others 14.25. Rest of Middle East & Africa Hypertension Management Devices Market Forecast, by Technology 14.25.1. Radiofrequency Ablation 14.25.2. Ultrasound 14.25.3. Micro-infusion 14.25.4. Others 14.26. Rest of Middle East & Africa Hypertension Management Devices Market Forecast, by End User 14.26.1. Hospitals 14.26.2. Ambulatory care Settings 14.26.3. Clinics 14.26.4. Home Care 14.27. Middle East & Africa Hypertension Management Devices Market Attractiveness Analysis 14.27.1. by Device Type 14.27.2. by Technology 14.27.3. by End User 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America Hypertension Management Devices Market Analysis 15.1. Key Findings 15.2. South America Hypertension Management Devices Market Overview 15.3. South America Hypertension Management Devices Market Value Share Analysis, by Device Type 15.4. South America Hypertension Management Devices Market Forecast, by Device Type 15.4.1. Renal Denervation Devices 15.4.2. Carotid Sinus Stimulation Devices 15.4.3. Others 15.5. South America Hypertension Management Devices Market Value Share Analysis, by Technology 15.6. South America Hypertension Management Devices Market Forecast, by Technology 15.6.1. Radiofrequency Ablation 15.6.2. Ultrasound 15.6.3. Micro-infusion 15.6.4. Others 15.7. South America Hypertension Management Devices Market Value Share Analysis, by End User 15.8. South America Hypertension Management Devices Market Forecast, by End User 15.8.1. Hospitals 15.8.2. Ambulatory care Settings 15.8.3. Clinics 15.8.4. Home Care 15.9. South America Hypertension Management Devices Market Value Share Analysis, by Country 15.10. South America Hypertension Management Devices Market Forecast, by Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America Hypertension Management Devices Market Analysis, by Country 15.12. Brazil Hypertension Management Devices Market Forecast, by Device Type 15.12.1. Renal Denervation Devices 15.12.2. Carotid Sinus Stimulation Devices 15.12.3. Others 15.13. Brazil Hypertension Management Devices Market Forecast, by Technology 15.13.1. Radiofrequency Ablation 15.13.2. Ultrasound 15.13.3. Micro-infusion 15.13.4. Others 15.14. Brazil Hypertension Management Devices Market Forecast, by End User 15.14.1. Hospitals 15.14.2. Ambulatory care Settings 15.14.3. Clinics 15.14.4. Home Care 15.15. Colombia Hypertension Management Devices Market Forecast, by Device Type 15.15.1. Renal Denervation Devices 15.15.2. Carotid Sinus Stimulation Devices 15.15.3. Others 15.16. Colombia Hypertension Management Devices Market Forecast, by Technology 15.16.1. Radiofrequency Ablation 15.16.2. Ultrasound 15.16.3. Micro-infusion 15.16.4. Others 15.17. Colombia Hypertension Management Devices Market Forecast, by End User 15.17.1. Hospitals 15.17.2. Ambulatory care Settings 15.17.3. Clinics 15.17.4. Home Care 15.18. Argentina Hypertension Management Devices Market Forecast, by Device Type 15.18.1. Renal Denervation Devices 15.18.2. Carotid Sinus Stimulation Devices 15.18.3. Others 15.19. Argentina Hypertension Management Devices Market Forecast, by Technology 15.19.1. Radiofrequency Ablation 15.19.2. Ultrasound 15.19.3. Micro-infusion 15.19.4. Others 15.20. Argentina Hypertension Management Devices Market Forecast, by End User 15.20.1. Hospitals 15.20.2. Ambulatory care Settings 15.20.3. Clinics 15.20.4. Home Care 15.21. Rest of South America Hypertension Management Devices Market Forecast, by Device Type 15.21.1. Renal Denervation Devices 15.21.2. Carotid Sinus Stimulation Devices 15.21.3. Others 15.22. Rest of South America Hypertension Management Devices Market Forecast, by Technology 15.22.1. Radiofrequency Ablation 15.22.2. Ultrasound 15.22.3. Micro-infusion 15.22.4. Others 15.23. Rest of South America Hypertension Management Devices Market Forecast, by End User 15.23.1. Hospitals 15.23.2. Ambulatory care Settings 15.23.3. Clinics 15.23.4. Home Care 15.24. South America Hypertension Management Devices Market Attractiveness Analysis 15.24.1. by Device Type 15.24.2. by Technology 15.24.3. by End User 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Component, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Component 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Medtronic Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Boston Scientific 16.3.3. Cordis 16.3.4. St. Jude Medical 16.3.5. Recor Medical 16.3.6. Intercure 16.3.7. CVRX 16.3.8. Mercator Medsystems 16.3.9. Kona Medical 16.3.10. Abbott 16.3.11. Ablative Solutions Inc. 16.3.12. PhysioCue 17. Primary key Insights